‘superDimension’ To Be Sold To Covidien Plc For $350M

Medical device company superDimension is in the process of being acquired by Covidien Plc, for $350 million, Israeli website Calcalist reported. The deal is anticipated to be sealed by the end of this week. superDimension develops pulmonary devices that are mostly used to diagnose lung cancer. It was founded in 1995 in Israel and is headquartered in Minneapolis. View and share